Who owns Protara Therapeutics, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of TARA from SEC Form 13F filings across 119 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 119 institutions disclosed 46.1M shares of Protara Therapeutics, Inc. worth $176.0M — about 75.5% of shares outstanding; the largest disclosed holder is Jupiter Topco LLC. Source: SEC Form 13F filings, parsed by EvidInvest.
119
13F holders
$176.0M
value, 2026 filers
75.5%
of shares outstanding (46.1M sh)
25
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of TARA's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | Jupiter Topco LLCNEW | 4.7M | $17.9M | 0.0% | 7.7% | new |
| 2 | BlackRock, Inc. | 3.7M | $14.0M | 0.0% | 6% | +7.9% |
| 3 | MILLENNIUM MANAGEMENT LLC | 3.1M | $11.8M | 0.0% | 5.1% | +9.5% |
| 4 | Velan Capital Investment Management LP | 2.8M | $10.9M | 6.6% | 4.7% | +0.4% |
| 5 | VANGUARD CAPITAL MANAGEMENT LLC | 2.3M | $8.8M | 0.0% | 3.8% | +8.5% |
| 6 | Blackstone Inc. | 2.3M | $8.7M | 0.0% | 3.7% | 0.0% |
| 7 | ORBIMED ADVISORS LLCNEW | 2.2M | $8.5M | 0.2% | 3.6% | new |
| 8 | Sio Capital Management, LLC | 1.9M | $7.3M | 1.2% | 3.2% | -2.4% |
| 9 | ACORN CAPITAL ADVISORS, LLC | 1.8M | $6.7M | 1.8% | 2.9% | 0.0% |
| 10 | Integral Health Asset Management, LLC | 1.5M | $5.7M | 0.2% | 2.5% | -14.3% |
| 11 | 5AM Venture Management, LLC | 1.4M | $5.2M | 1.8% | 2.2% | 0.0% |
| 12 | GEODE CAPITAL MANAGEMENT, LLC | 1.3M | $5.1M | 0.0% | 2.2% | +12.7% |
| 13 | CITADEL ADVISORS LLC | 1.2M | $4.7M | 0.0% | 2% | +15.3% |
| 14 | STATE STREET CORP | 1.1M | $4.1M | 0.0% | 1.8% | +6.3% |
| 15 | Qube Research & Technologies Ltd | 1.0M | $4.0M | 0.0% | 1.7% | +490.7% |
| 16 | Balyasny Asset Management L.P.NEW | 1.0M | $3.9M | 0.0% | 1.7% | new |
| 17 | BAKER BROS. ADVISORS LP | 971,614 | $3.7M | 0.0% | 1.6% | 0.0% |
| 18 | ADAR1 Capital Management, LLC | 940,512 | $3.6M | 0.2% | 1.5% | 0.0% |
| 19 | BANK OF AMERICA CORP /DE/ | 882,179 | $3.4M | 0.0% | 1.4% | -4.7% |
| 20 | MARSHALL WACE, LLP | 701,021 | $2.7M | 0.0% | 1.1% | +1281.8% |
| 21 | DIMENSIONAL FUND ADVISORS LP | 683,230 | $2.6M | 0.0% | 1.1% | +28.6% |
| 22 | NORTHERN TRUST CORP | 552,306 | $2.1M | 0.0% | 0.9% | +47.3% |
| 23 | Point72 Asset Management, L.P. | 548,932 | $2.1M | 0.0% | 0.9% | -52.4% |
| 24 | GOLDMAN SACHS GROUP INC | 546,227 | $2.1M | 0.0% | 0.9% | +37.2% |
| 25 | Catalio Capital Management, LP | 520,148 | $2.0M | 0.4% | 0.9% | -10.3% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.